...An assignment on BEXIMCO PHARMACEUTICALS LTD Submitted To Professor Dr. Durgadas Bhattacherjee Adjunct Professor Department of Business Administration Faculty of Business & Economics Submitted By Md. Amjad Hosen ID: 151-12-596 Semester: Summer 2015 Subject: Strategic Management Program: E.M.B.A Section: ‘B’ DAFFODIL INTERNATIONAL UNIVERSITY Date of Submission: August 09, 2015 Table of Content | Topic Pages 1. Historical Background 2. Company profile 3. Organizational Structure 4. Product Line 5. Market Scenario 6. Business level Strategy Pursued 7. Competitive Advantage 8. SWOT Analysis 9. Possible Measures to Improve Performance 10. Relationship between Business Level Strategy and Performance 11. What I Learned 12. Conclusion Historical Background Beximco Pharma is a leading edge pharmaceutical company and is a member of the Beximco Group, the largest private sector industrial conglomerate in Bangladesh. The firm started operation in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA and now have grown to become nation's one of the leading pharmaceutical companies, supplying more than...
Words: 2662 - Pages: 11
...the Pharmaceutical Division. The factory is equipped with the state of the art facilities for product formulations and process innovation. These include modern computerized equipment like HPLC and GLC. The product range manufactured at ACI FL include Crop Protection Chemicals like Insecticides, herbicides and fungicides in granular, powder and liquid, mosquito pesticides in the forms of aerosols, vaporizers and coils house hold chemicals like toilet cleaners and hand wash. History: ACI Limited was established as the subsidiary of Imperial Chemical Industries (ICI) in the then East Pakistan in 1968. After independence, the company was incorporated in Bangladesh in 1973 as ICI Bangladesh Manufacturers limited as a Public Limited Company. In 1992, the company was divested to local management and the name of the company changed to Advanced Chemical Industries (ACI) Limited. ACI inherited the rich ICI culture of product quality, customer service and social responsibility. Initially in 1992, ACI started primarily with pharmaceutical business with a turnover of BDT 80 million only but later the new management brought about fundamental changes in the policies and in the year 2008 turnover grew to over BDT 7,365 million. The Company has diversified business interest in pharmaceuticals, agricultural including fishery & livestock and consumer brands. At present, ACI has three strategic business units along with 11 subsidiaries, 3 joint ventures and 1 associate. Company profile ACI...
Words: 490 - Pages: 2
...Pharmaceutical industry The pharmaceutical industry develops, produces, and markets drugs licensed for use as medications.[1] Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices. They are subject to a variety of laws and regulations regarding the patenting, testing and ensuring safety and efficacy and marketing of drugs. Indian Pharmaceutical Industry The pharmaceutical industry in India is among the most highly organized sectors. This industry plays an important role in promoting and sustaining development in the field of global medicine. Due to the presence of low cost manufacturing facilities, educated and skilled manpower and cheap labor force among others, the industry is set to scale new heights in the fields of production, development, manufacturing and research. In 2008, the domestic pharma market in India was expected to be US$ 10.76 billion and this is likely to increase at a compound annual growth rate of 9.9 per cent until 2010 and subsequently at 9.5 per cent till the year 2015. | Industry Trends : * The pharma industry generally grows at about 1.5-1.6 times the Gross Domestic Product growth * Globally, India ranks third in terms of manufacturing pharma products by volume * The Indian pharmaceutical industry is expected to grow at a rate of 9.9 % till 2010 and after that 9.5 % till 2015 * In 2007-08, India exported drugs worth US$7.2 billion in to the US and Europe followed by Central and Eastern...
Words: 2809 - Pages: 12
...1. Historical background Beximco Pharmaceuticals Limited (BPL) is a part of Beximco Group, the largest private sector industrial conglomerate in Bangladesh. BPL develops, manufactures and markets both finished dosage form branded generic pharmaceutical products and active pharmaceutical ingredients (APIs), with products including solid dose forms, Metered Dose Inhalers, Nasal Sprays, Large Volume Intravenous Fluids, Suppositories, and Creams/Ointments. BPL produces and markets 'branded generics' for most diseases ranging from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets. The company also manufactures active pharmaceutical ingredients and intravenous fluids and contract manufacture for major international brands of leading multinational companies. BPL utilizes state of the art manufacturing facilities. BPL also has outstanding reverse engineering capabilities. Incorporated in 1976, BPL started off as a distributor of pharmaceutical products. It imported products from global MNCs such as Bayer AG of Germany and Upjohn Inc. of USA and sold them in the local market. It eventually graduated to a manufacturer and distributor of these products in local market under licensing agreements. During the early 80s, BPL launched its own products in the local market. Beximco started its exports operation in the early 90s with APIs. Today BPL is one of the largest exporters of medicines from Bangladesh. BPL employs more...
Words: 1988 - Pages: 8
...PHRMA Table of Contents 1) Introduction page 3 2) History/Overview of the Industry page 3 3) Economic Characteristics page 4 a) Structure b) Costs c) Demand d) Competition- The Rise of the Generics e) Market Failure, Government Intervention and Price 4) Performance page 7 5) Impact of the Global Economic Downturn page 9 6) Summary page 10 7) Conclusion page 11 Bibliography page 12 8) 1. Introduction This paper briefly examines the current state of the pharmaceutical industry, as well as the economic characteristics, performance, and the impact of the global recession. The industry is made up of several enterprises engaging in the research, development, manufacture and marketing of medicines, vaccines, medical devices, and nutritional products for humans and animals. Though, this multi-billion dollar industry includes large ethical drug multi-nationals (often referred to as Big Pharma), mid-sized specialty pharmaceutical companies, manufacturers of generics, small biotechnology and biopharmaceutical firms, and service companies, 1 for the purpose of this paper, the emphasis will be mainly on drug makers. 2. History/Overview of the Industry The pharmaceutical industry of today is a far cry from its humble beginnings in the nineteenth century of physicians mainly prescribing plant extracts to being technology intensive, dominated by a few...
Words: 2796 - Pages: 12
...FINAL GROUP REPORT ON “RADHUNI” [pic] Letter of Transmittal 27th April, 2010 Sumon, Stanley Rodrick The course teacher Principle of management American International University Bangladesh Banani, Dhaka-1213. Subject: Submission of report. Dear Sir, It is our great pleasure to put forward this report that you assigned us on “A study on a Brand” which is the “RADHUNI”. We have tried our best to bring about our research objective effectively. Under your supervision we have completed our respective job. In our observation we tried to find out the present situation and try to present in our report. By doing this report we have learned many things that will help us in the future. This is a real life report so that we will always be available for any supplementary that may oblige. We are giving you thanks again for giving us a chance to present a report to you and hope it will positively help us. Yours Sincerely, • Roy,Supta • Siju,Mariyam Akhter • Shanta,Sharmin Shahin • Ahmed,Salvana • Chowdhury,Farzana Mustafa Acknowledgement i) Acknowledgement: First of all we would like to thank the Almighty for giving us the time, patience, energy and will power to finish this assignment. Then we would like to thank our course instructor Mr. Sumon, Stanley Rodrick for making us do this assignment...
Words: 2307 - Pages: 10
...AN EXPLORATORY STUDY ON THE EXPORT POTENTIAL AND STRATEGIES OF BEXIMCO PHARMACEUTICALS LTD. [pic] [pic] [pic] AN EXPLORATORY STUDY ON THE EXPORT POTENTIAL AND STRATEGIES OF BEXIMCO PHARMACEUTICALS LTD. Submitted To: Professor Golam Mohammed Chowdhury Chairman Internship and Placement Program Supervised By: Mr. Ridwanul Huq Lecturer Submitted by: Md. Shoeb-Bin-Mananan MBA 38th Day Roll-38D Institute of Business Administration University of Dhaka July 08, 2010 July 08, 2010 Professor Golam Mohammed Chowdhury The Chairperson Internship and Placement Committee Institute of Business Administration University of Dhaka Subject: Submission of Internship Report. Dear Sir, It is my pleasure to submit the internship report, which is done as a part of academic curriculum, to you for your kind evaluation. The report is prepared on “The Export Potential and Strategies of BEXIMCO Pharmaceuticals Ltd”. My organizational supervisor assigned me to prepare a report on the above mentioned subject and later my faculty advisor also approved it. I have put my best effort in preparing this report and to make it a worthy one. Each aspect of the problem is considered and studied as required. I shall try my best and shall be obliged to provide you with any kind of clarification concerning this report. Sincerely yours, ____________ Md. Shoeb-Bin-Mananan Roll No.: 38 Batch : 38th (Day) Major:...
Words: 10200 - Pages: 41
...Administration Submitted by K.PRAKASH ( Reg.no : 10183135) Under the guidance of Mr.S.BALASUBRAMANIAN name Company guide faculty guide Department of Business Administration (Self– finance) N.M.S.S.VELLAICHAMY NADAR COLLEGE (An autonomous Institution Accredited with the A by NACC) An ISO 9001: 2008 certified institution Madurai -625019 2012 Training company certificate can be add the page N.M.S.S.VELLAICHAMY NADAR COLLEGE (An autonomous Institution Accredited with the A by NACC) An ISO 9001: 2008 certified institution Madurai -625019 BONAFIDE CERTIFICATE BACHELOR OF BUSINESS ADMINISTRATION ( Self – finance ) This is to certify that this bonafide of the training work done by K.PRAKASH NO : 10183135 during the period of June in partial fulfillment of the requirement for the award of the degree BBA (Bachelor of Business Administration) N.M.S.S.VELLAICHAMY NADAR COLLEGE Submitted for viva voce examination on Name Faculty guide External Guide Mrs.L.Sugirtha M.B.A., M.Com, M.Phil, PGDCA The Head of the Department, Department of BBA N.M.S.S.VELLAICHAMY NADAR COLLEGE Nagamalai, Madurai...
Words: 4068 - Pages: 17
...ORGANISING YOUR MATERIAL 9 AND HEADINGS TACKLING WORK PERMIT ISSUES 10 Fig. 9 Nationality and Work Permission Data WRITING PERSONAL PROFILES 12 Fig 10. Personal Profile Statement Fig 11: Career Objective Statement Fig 12: Career Summary Fig 13: Expertise Summary BEAUTIFUL BULLETS 13 Fig 14: Bullet 1 Fig 15: A Powerful Summary SHOWING MANAGERIAL CAPABILITIES 14 REFERENCES 14 Fig 16. References SCANNING YOUR WORK 15 CV EXAMPLES PROFILE EXAMPLES EXAMPLE COVERING LETTER 16-28 29-30 31 5. 6. 7. 8. 9. 10. 11. 12. 13. 14 15. CV EXAMPLES 2 INTRODUCTION 1. YOUR CV Welcome. If you are a postgraduate student at The Birmingham Business School, one of the tasks you are likely to want to tackle is the design of a CV to ‘market’ your skills for the future. Even if you do not intend to try and seek work in the UK, you are likely to find that you can learn from the self-marketing skills our Careers Advisers and Consultants will emphasise in the workshop sessions offered and by working on your CV using this Guide. You are likely to achieve the best result if you review your CV more than once during your course. The review process will strengthen your CV so it reflects your learning, development and changing ideas about work options. MBAs at The Birmingham Business School will be asked to design a Profile, to go on-line. However, this profile format will not...
Words: 9018 - Pages: 37
...and joint ventures. Strategies are potential actions that require top management decision and large amount of farm’s resources. Additionally strategies affect an organization’s long term prosperity, typically for at least five years, and thus are future oriented. Strategies have multifunctional and multidivisional consequences and required consideration of both the external and internal factors facing the firm. Most Strategic Management Model There are several Strategic Models are available and used in different organizations but following are the most used strategic models: 1. PEST analysis 2. STEER Analysis 3. Five Forces Model 4. Strategic Group Map 5. SWOT analysis 6. Blue Ocean Strategies 7. Open innovation 8. McKinsey seven S model Company Detailed Profile including mission & vision and Organogram Company Detail Profile Square pharmaceutical is now the most leading company in Bangladesh since 1985 and is now on its way to becoming a high performance global player. Today it has achieved a state of mind among consumers. This company has founded in 1958 and since then with hard work and dedication among employees and top management, it has reached the position where every pharmaceutical company wants to reach. Square went public in 1991 and is currently listed on the Dhaka Stock Exchange and Chittagong Stock Exchange. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership...
Words: 5122 - Pages: 21
...------------------------------------------------- WORK EXPERIENCE Torrent Power (24 months) Back office Executive Responsibilities: * Attend customers * Handling cash counters and help desk * Registration of the complaints * Sorting out problems and queries by allocating the work among respected departments * Taking care task time line and tracking follow up. ------------------------------------------------- PROJECTS UNDERTAKEN PGP Dissertation: (8th February, 2011 to 10th April, 2011) Name of the project: PGP dissertation project report on FILGRASTIM molecule. Description: During the PGP Dissertation project I am going to make strategy marketing plan of FILGRASTIM molecule. * Analyze the market scenario of the selected molecule. * Analyze the research and development happening in area of selected molecule. * To prepare Strategic marketing plan. Live Project: (25th October to 14th December 2010) Name of the Company: Lincoln Pharmaceuticals LTD. Name of the Project: “Marketing plan on Ferrous bisglycinate. Description of the...
Words: 631 - Pages: 3
...INTERNSHIP REPORT INTERNSHIP REPORT T R E N D A N A L YS I S OF G E N E R I C S H I F T I NG I N T H E B A NG L A DE S H PHARMACEUTICAL MARKET (2006-2010) EMPLOYEE ORGANIZATION: SQUARE PHARMACEUTICALS LTD BANGLADESH PREPARED BY Monamee Afroze Ishika ID: 07104021 BRAC Business School BRAC University PREPARED FOR Mr. Anup Chowdhury Assistant Professor BRAC Business School BRAC University DATE of SUBMISSION 8th December, 2010 Transmittal Message December 08, 2010 Mr. Anup Chowdhury Assistant Professor, BRAC Business School BRAC University Subject: Submission of Internship Report Dear Sir, With great pleasure I am submitting my Internship report on Trend Analysis of Generic Shifting in the Bangladesh Pharmaceutical Market (2006-2010). I got the opportunity to work at country’s leading pharmaceutical company, world reputed Square Pharmaceuticals Limited (SPL) and was placed under one of the most important departments in the company Product Management Department (PMD). I have found the experience to be quite interesting and under the guidance of my supervisors and with the help of all the members of the department I have tried my level best to prepare an effective report on the above mentioned topic. The report contains the trend analysis of generic shifting, the reasons behind it and future potentiality of certain generic shifting events and SPL’s planning in the present scenario. Here I have gathered data and information through actual...
Words: 26333 - Pages: 106
...ACI Company Profile: CI Bangladesh Manufacturers Limited was a subsidiary of world renowned multinational ICI Plc and was a listed public limited company under Dhaka Stock Exchange. In 1992 ICI Plc divested its shareholding through a management buyout and the company name was changed from ICI Bangladesh Manufacturers Limited to Advanced Chemical Industries (ACI) Limited. ACI Formulations Limited, a subsidiary of ACI, became a public listed company through direct listing. ACI has diversified into four major strategic business divisions which include Health Care, Consumer Brands, Agribusinesses and Retail Chain. ACI's mission is to achieve business excellence through quality by understanding, accepting, meeting and exceeding customer expectations. ACI follows International Standards on Quality Management System to ensure consistent quality of products and services to achieve customer satisfaction. ACI also meets all national regulatory requirements relating to its current businesses and ensures that current Good Manufacturing Practices (cGMP) as recommended by World Health Organization is followed properly. ACI has been accepted as a Founding Member of the Community of Global Growth Companies by the World Economic Forum which is the most prestigious business networking organization. ACI formulates and markets a comprehensive range of more than 387 products covering all major therapeutic areas, which come in tablet, capsule, powder, liquid, cream, ointment, gel ,ophthalmic...
Words: 676 - Pages: 3
..., COMPANY PROFILE Company profile-Novus pharmaceuticals ltd is a new strategies business unit (SBU) of Abdul Monem group. The group has a long reputation as the best road construction company of the country. More over the group has two block buster brands Coca-Cola, igloo ice-cream. Bangladesh pharmacy markets have known to be one of the best value addition sectors among all industries. With better urbanization and economic upliftment people will have more access to modern medicines. Novus will capitalize this opportunity by offering highest quality medicines at an affordable cost to serve people locally and globally. Combining the group image and applying appropriate marketing strategies Novus will established itself as a leading player Bangladesh pharmacy market. Company Index Score Current Index Score Historical Index Score * Novus Pharmaceuticals Ltd. currently scores 50% in the index. * Novus Pharmaceuticals Ltd. is currently ranked equal 10 out of 4206. This is in the top 0.24% of Parma companies ranked in the index. * Novus Pharmaceuticals Ltd. is currently ranked equal 19 out of a total of 35419 included in the Info Grok Company Index. This is the top 0.05% of all companies. * User perception of the company stands at 50%. This differs 0% over the score attributed to the company by other scoring factors. Mission & Vision Mission To become the most valued partner of customer care by researching...
Words: 2998 - Pages: 12
...GlaxoSmithKline company profile Francis Weyzig Amsterdam, October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000 GSK key figures for 2003 (in £ million) Sales 21,441 Materials and production costs 4,188 Marketing and administration 7,563 R&D expenditures 2,770 Operating income 6,920 Net profit 4,765 GSK has two main business divisions, pharmaceuticals and consumer healthcare. This profile deals with the pharmaceuticals division, which generates 85% of GSK’s sales. The five largest selling GSK products are Seretide/Advair for asthma and Chronic Obstructive Pulmonary Disease (COPD); Paxil/Seroxat and Wellbutrin, both antidepression drugs; Avandia/Avadamet for type 2 diabetes; and the antibiotic Augmentin. Each of these drugs generated above £800 million of sales in 2003. GSK produces a broad range of products of special importance to developing countries, including: Anti-malaria drugs Zentel (albendazole), for de-worming and the prevention of lymphatic filariasis Pentosam, against leishmaniasis Anti-retrovirals (ARVs) for the treatment of HIV/AIDS Tuberculosis drugs Vaccines for developing countries Corporate...
Words: 18642 - Pages: 75
